Literature DB >> 10439901

Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail.

T Nakai1, R Sugimoto, K H Park, S Matsuoka, K Mori, T Nishioka, K Maruyama.   

Abstract

The present study describes the in vitro and in vivo survival of Lactococcus garvieae bacteriophages and the potential of the phage for controlling experimental L. garvieae infection in yellowtail. Anti-L. garvieae phages persisted well in various physicochemical (water temperature, salinity, pH) and biological (feed, serum and alimentary tract extracts of yellowtail) conditions, except for low acidity. In the in vivo, the phage PLgY-16 was detected in the spleens of yellowtail until 24 h after intraperitoneal (i.p.) injection, or the phage was recovered from the intestine of yellowtail 3 h after the oral administration of phage-impregnated feed but undetectable 10 h later. Simultaneous administration of live L. garvieae and phage enhanced recovery of the phage from the spleen or intestine. The survival rate was much higher in yellowtail that received i.p. injection of the phage after i.p. challenge with L. garvieae, compared with that of control fish without phage injection. When fish were i.p. injected with phage at different hours after L. garvieae challenge, higher protective effects were demonstrated in fish that received phage treatment at the earlier time. Protection was also obtained in yellowtail receiving phage-impregnated feed, in which fish were challenged by an anal intubation with L. garvieae. Anal-intubated L. garvieae were detected constantly in the spleens of the control fish, while they were detected sporadically and disappeared from the phage-treated fish 48 h later. On the other hand, orally administered phage was detected at high plaque-forming units from the intestines and spleens of the phage-treated fish until 48 h later. These results indicate that intraperitoneally or orally administered anti-L. garvieae phage prevented fish from experimental L. garvieae infection, suggesting potential use of the phage for controlling the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10439901     DOI: 10.3354/dao037033

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  30 in total

Review 1.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Influence of some environmental variables and addition of r-lysozyme on efficacy of Vibrio harveyi phage for therapy.

Authors:  Tanmoy Gon Choudhury; Biswajit Maiti; M N Venugopal; Indrani Karunasagar
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

3.  Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.

Authors:  Quintin F Wills; Claire Kerrigan; James S Soothill
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control.

Authors:  S C Park; I Shimamura; M Fukunaga; K I Mori; T Nakai
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

5.  Vibriophages and their interactions with the fish pathogen Vibrio anguillarum.

Authors:  Demeng Tan; Lone Gram; Mathias Middelboe
Journal:  Appl Environ Microbiol       Date:  2014-03-07       Impact factor: 4.792

Review 6.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

7.  Vibriophages Differentially Influence Biofilm Formation by Vibrio anguillarum Strains.

Authors:  Demeng Tan; Amalie Dahl; Mathias Middelboe
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

8.  Diversity and geographical distribution of Flavobacterium psychrophilum isolates and their phages: patterns of susceptibility to phage infection and phage host range.

Authors:  Daniel Castillo; Rói Hammershaimb Christiansen; Romilio Espejo; Mathias Middelboe
Journal:  Microb Ecol       Date:  2014-02-21       Impact factor: 4.552

Review 9.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

10.  A virulent phage infecting Lactococcus garvieae, with homology to Lactococcus lactis phages.

Authors:  Giovanni Eraclio; Denise M Tremblay; Alexia Lacelle-Côté; Simon J Labrie; Maria Grazia Fortina; Sylvain Moineau
Journal:  Appl Environ Microbiol       Date:  2015-09-25       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.